{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T19:51:14Z","timestamp":1775073074397,"version":"3.50.1"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01NS096376"],"award-info":[{"award-number":["1R01NS096376"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01NS096376"],"award-info":[{"award-number":["1R01NS096376"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01NS096376"],"award-info":[{"award-number":["1R01NS096376"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-025-01959-4","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T02:31:38Z","timestamp":1747621898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Beyond the brain: exploring the impact of animal models of leptomeningeal disease from solid tumors"],"prefix":"10.1186","volume":"13","author":[{"given":"Jillyn R.","family":"Turunen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Kumthekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atique U.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"1959_CR1","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.3390\/cancers14061448","volume":"14","author":"H Adachi","year":"2022","unstructured":"Adachi H, Ito H, Sawabata N (2022) Circulating tumor cells and the non-touch isolation technique in surgery for non-small-cell lung cancer. Cancers (Basel) 14:1448. https:\/\/doi.org\/10.3390\/cancers14061448","journal-title":"Cancers (Basel)"},{"key":"1959_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s11060-023-04372-w","volume":"163","author":"AA Adile","year":"2023","unstructured":"Adile AA, Bakhshinyan D, Suk Y, Uehling D, Saini M, Aman A, Magolan J, Subapanditha MK, McKenna D, Chokshi C et al (2023) An effective kinase inhibition strategy for metastatic recurrent childhood medulloblastoma. J Neurooncol 163:635\u2013645. https:\/\/doi.org\/10.1007\/s11060-023-04372-w","journal-title":"J Neurooncol"},{"key":"1959_CR3","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3171\/2012.1.JNS111560","volume":"116","author":"JH Ahn","year":"2012","unstructured":"Ahn JH, Lee SH, Kim S, Joo J, Yoo H, Lee SH, Shin SH, Gwak HS (2012) Risk for leptomeningeal seeding after resection for brain metastases: implication of tumor location with mode of resection. J Neurosurg 116:984\u2013993. https:\/\/doi.org\/10.3171\/2012.1.JNS111560","journal-title":"J Neurosurg"},{"key":"1959_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41523-023-00519-0","volume":"9","author":"L Alder","year":"2023","unstructured":"Alder L, Trapani D, Bradbury C, Van Swearingen AED, Tolaney SM, Khasraw M, Anders CK, Lascola CD, Hsu L, Lin NU et al (2023) Durable responses in patients with HER2+ breast cancer and leptomeningeal metastases treated with trastuzumab deruxtecan. NPJ Breast Cancer 9:19. https:\/\/doi.org\/10.1038\/s41523-023-00519-0","journal-title":"NPJ Breast Cancer"},{"key":"1959_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/BF02057178","volume":"7","author":"AL Alterman","year":"1989","unstructured":"Alterman AL, Stackpole CW (1989) B16 melanoma spontaneous brain metastasis: occurrence and development within leptomeninges blood vessels. Clin Exp Metastasis 7:15\u201323. https:\/\/doi.org\/10.1007\/BF02057178","journal-title":"Clin Exp Metastasis"},{"key":"1959_CR6","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.1158\/0008-5472.CAN-21-0259","volume":"81","author":"KI Ansari","year":"2021","unstructured":"Ansari KI, Bhan A, Saotome M, Tyagi A, De Kumar B, Chen C, Takaku M, Jandial R (2021) Autocrine GMCSF signaling contributes to growth of HER2(+) breast leptomeningeal carcinomatosis. Cancer Res 81:4723\u20134735. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-0259","journal-title":"Cancer Res"},{"key":"1959_CR7","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jtho.2020.01.001","volume":"15","author":"S Arai","year":"2020","unstructured":"Arai S, Takeuchi S, Fukuda K, Taniguchi H, Nishiyama A, Tanimoto A, Satouchi M, Yamashita K, Ohtsubo K, Nanjo S et al (2020) Osimertinib overcomes alectinib resistance caused by amphiregulin in a leptomeningeal carcinomatosis model of ALK-rearranged lung cancer. J Thorac Oncol 15:752\u2013765. https:\/\/doi.org\/10.1016\/j.jtho.2020.01.001","journal-title":"J Thorac Oncol"},{"key":"1959_CR8","first-page":"2646","volume":"5","author":"GE Archer","year":"1999","unstructured":"Archer GE, Sampson JH, Lorimer IA, McLendon RE, Kuan CT, Friedman AH, Friedman HS, Pastan IH, Bigner DD (1999) Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1. Clin Cancer Res 5:2646\u20132652","journal-title":"Clin Cancer Res"},{"key":"1959_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1023\/a:1006304424346","volume":"44","author":"GE Archer","year":"1999","unstructured":"Archer GE, Sampson JH, McLendon RE, Friedman AH, Colvin OM, Rose M, Sands H, McCullough W, Fuchs HE, Bigner DD et al (1999) Intrathecal busulfan treatment of human neoplastic meningitis in athymic nude rats. J Neurooncol 44:233\u2013241. https:\/\/doi.org\/10.1023\/a:1006304424346","journal-title":"J Neurooncol"},{"key":"1959_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11060-024-04576-8","volume":"167","author":"T Baccili Cury Megid","year":"2024","unstructured":"Baccili Cury Megid T, Baskurt Z, Ma LX, Barron CC, Farooq A, Saltiel MP, Wang X, Bach Y, Ayoama H, Jang RW et al (2024) Leptomeningeal carcinomatosis and brain metastases in gastroesophageal carcinoma: a real-world analysis of clinical and pathologic characteristics and outcomes. J Neurooncol 167:111\u2013122. https:\/\/doi.org\/10.1007\/s11060-024-04576-8","journal-title":"J Neurooncol"},{"key":"1959_CR11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S1470-2045(10)70034-6","volume":"11","author":"P Beauchesne","year":"2010","unstructured":"Beauchesne P (2010) Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours. Lancet Oncol 11:871\u2013879. https:\/\/doi.org\/10.1016\/S1470-2045(10)70034-6","journal-title":"Lancet Oncol"},{"key":"1959_CR12","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1158\/0008-5472.CAN-20-3317","volume":"81","author":"A Bhan","year":"2021","unstructured":"Bhan A, Ansari KI, Chen MY, Jandial R (2021) Inhibition of jumonji histone demethylases selectively suppresses HER2(+) breast leptomeningeal carcinomatosis growth via inhibition of GMCSF expression. Cancer Res 81:3200\u20133214. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-3317","journal-title":"Cancer Res"},{"issue":"1101\u20131113","key":"1959_CR13","doi-asserted-by":"publisher","first-page":"e1113","DOI":"10.1016\/j.cell.2017.02.025","volume":"168","author":"A Boire","year":"2017","unstructured":"Boire A, Zou Y, Shieh J, Macalinao DG, Pentsova E, Massague J (2017) Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis. Cell 168(1101\u20131113):e1113. https:\/\/doi.org\/10.1016\/j.cell.2017.02.025","journal-title":"Cell"},{"key":"1959_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000489484","volume":"139","author":"M Bommer","year":"2018","unstructured":"Bommer M, Kull M, Teleanu V, Schwarzwalder P, Feuring-Buske M, Kroenke J, Bunjes D, Langer C (2018) Leptomeningeal myelomatosis: a rare but devastating manifestation of multiple myeloma diagnosed using cytology, flow cytometry, and fluorescent in situ hybridization. Acta Haematol 139:247\u2013254. https:\/\/doi.org\/10.1159\/000489484","journal-title":"Acta Haematol"},{"key":"1959_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1023\/b:neon.0000027742.78828.99","volume":"68","author":"D Brandsma","year":"2004","unstructured":"Brandsma D, Taphoorn MJ, Reijneveld JC, Nas TM, Voest EE, Nicolay K, Blezer E (2004) MR imaging of mouse leptomeningeal metastases. J Neurooncol 68:123\u2013130. https:\/\/doi.org\/10.1023\/b:neon.0000027742.78828.99","journal-title":"J Neurooncol"},{"issue":"855\u2013870","key":"1959_CR16","doi-asserted-by":"publisher","first-page":"e811","DOI":"10.1016\/j.stem.2019.10.005","volume":"25","author":"M Cancer","year":"2019","unstructured":"Cancer M, Hutter S, Holmberg KO, Rosen G, Sundstrom A, Tailor J, Bergstrom T, Garancher A, Essand M, Wechsler-Reya RJ et al (2019) Humanized stem cell models of pediatric medulloblastoma reveal an Oct4\/mTOR axis that promotes malignancy. Cell Stem Cell 25(855\u2013870):e811. https:\/\/doi.org\/10.1016\/j.stem.2019.10.005","journal-title":"Cell Stem Cell"},{"key":"1959_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1750-3639.2010.00468.x","volume":"21","author":"V Caretti","year":"2011","unstructured":"Caretti V, Zondervan I, Meijer DH, Idema S, Vos W, Hamans B, Bugiani M, Hulleman E, Wesseling P, Vandertop WP et al (2011) Monitoring of tumor growth and post-irradiation recurrence in a diffuse intrinsic pontine glioma mouse model. Brain Pathol 21:441\u2013451. https:\/\/doi.org\/10.1111\/j.1750-3639.2010.00468.x","journal-title":"Brain Pathol"},{"key":"1959_CR18","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1126\/science.aaz2193","volume":"369","author":"Y Chi","year":"2020","unstructured":"Chi Y, Remsik J, Kiseliovas V, Derderian C, Sener U, Alghader M, Saadeh F, Nikishina K, Bale T, Iacobuzio-Donahue C et al (2020) Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis. Science 369:276\u2013282. https:\/\/doi.org\/10.1126\/science.aaz2193","journal-title":"Science"},{"key":"1959_CR19","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.1158\/0008-5472.CAN-12-0755","volume":"72","author":"HR Cho","year":"2012","unstructured":"Cho HR, Wen H, Ryu YJ, An YJ, Kim HC, Moon WK, Han MH, Park S, Choi SH (2012) An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis. Cancer Res 72:5179\u20135187. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-0755","journal-title":"Cancer Res"},{"key":"1959_CR20","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/s41467-020-15585-2","volume":"11","author":"PED Chung","year":"2020","unstructured":"Chung PED, Gendoo DMA, Ghanbari-Azarnier R, Liu JC, Jiang Z, Tsui J, Wang DY, Xiao X, Li B, Dubuc A et al (2020) Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy. Nat Commun 11:1825. https:\/\/doi.org\/10.1038\/s41467-020-15585-2","journal-title":"Nat Commun"},{"key":"1959_CR21","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/WNL.0b013e3181dc1a69","volume":"74","author":"JL Clarke","year":"2010","unstructured":"Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM (2010) Leptomeningeal metastases in the MRI era. Neurology 74:1449\u20131454. https:\/\/doi.org\/10.1212\/WNL.0b013e3181dc1a69","journal-title":"Neurology"},{"key":"1959_CR22","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1158\/0008-5472.CAN-08-0041","volume":"68","author":"W Cruz-Munoz","year":"2008","unstructured":"Cruz-Munoz W, Man S, Xu P, Kerbel RS (2008) Development of a preclinical model of spontaneous human melanoma central nervous system metastasis. Cancer Res 68:4500\u20134505. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0041","journal-title":"Cancer Res"},{"key":"1959_CR23","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1158\/1535-7163.MCT-21-0140","volume":"20","author":"J Deng","year":"2021","unstructured":"Deng J, Chernikova SB, Wang Y, Rodriguez ML, Andersen SJ, Umeh-Garcia MC, Godfrey BO, Ahmadian SS, Fischer WN, Koller KJ et al (2021) A novel brain-permeant chemotherapeutic agent for the treatment of brain metastasis in triple-negative breast cancer. Mol Cancer Ther 20:2110\u20132116. https:\/\/doi.org\/10.1158\/1535-7163.MCT-21-0140","journal-title":"Mol Cancer Ther"},{"key":"1959_CR24","doi-asserted-by":"publisher","DOI":"10.15761\/BG.1000101","author":"RA Elansari","year":"2016","unstructured":"Elansari RA, Abada R, Rouadi S, Roubal M (2016) Leptomeningeal carcinomatosis unusual clinical presentation from insidious anaplasic thyroid carcinoma. Biomark Gene. https:\/\/doi.org\/10.15761\/BG.1000101","journal-title":"Biomark Gene"},{"key":"1959_CR25","doi-asserted-by":"crossref","unstructured":"Engebraaten O, Fodstad O (1999) Site-specific experimental metastasis patterns of two human breast cancer cell lines in nude rats. Int J Cancer 82:219\u2013225. https:\/\/doi.org\/10.1002\/(sici)1097-0215(19990719)82:2<219::aid-ijc12>3.0.co;2-#","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<219::AID-IJC12>3.0.CO;2-#"},{"key":"1959_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1023\/a:1006329410433","volume":"18","author":"IJ Fidler","year":"1999","unstructured":"Fidler IJ, Schackert G, Zhang RD, Radinsky R, Fujimaki T (1999) The biology of melanoma brain metastasis. Cancer Metastasis Rev 18:387\u2013400. https:\/\/doi.org\/10.1023\/a:1006329410433","journal-title":"Cancer Metastasis Rev"},{"key":"1959_CR27","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1038\/s41467-023-43242-x","volume":"14","author":"A Fitzpatrick","year":"2023","unstructured":"Fitzpatrick A, Iravani M, Mills A, Vicente D, Alaguthurai T, Roxanis I, Turner NC, Haider S, Tutt ANJ, Isacke CM (2023) Genomic profiling and pre-clinical modelling of breast cancer leptomeningeal metastasis reveals acquisition of a lobular-like phenotype. Nat Commun 14:7408. https:\/\/doi.org\/10.1038\/s41467-023-43242-x","journal-title":"Nat Commun"},{"key":"1959_CR28","first-page":"4710","volume":"54","author":"HS Friedman","year":"1994","unstructured":"Friedman HS, Archer GE, McLendon RE, Schuster JM, Colvin OM, Guaspari A, Blum R, Savina PA, Fuchs HE, Bigner DD (1994) Intrathecal melphalan therapy of human neoplastic meningitis in athymic nude rats. Cancer Res 54:4710\u20134714","journal-title":"Cancer Res"},{"key":"1959_CR29","first-page":"1954","volume":"50","author":"HE Fuchs","year":"1990","unstructured":"Fuchs HE, Archer GE, Colvin OM, Bigner SH, Schuster JM, Fuller GN, Muhlbaier LH, Schold SC Jr, Friedman HS, Bigner DD (1990) Activity of intrathecal 4-hydroperoxycyclophosphamide in a nude rat model of human neoplastic meningitis. Cancer Res 50:1954\u20131959","journal-title":"Cancer Res"},{"key":"1959_CR30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/00008390-199610000-00003","volume":"6","author":"T Fujimaki","year":"1996","unstructured":"Fujimaki T, Price JE, Fan D, Bucana CD, Itoh K, Kirino T, Fidler IJ (1996) Selective growth of human melanoma cells in the brain parenchyma of nude mice. Melanoma Res 6:363\u2013371. https:\/\/doi.org\/10.1097\/00008390-199610000-00003","journal-title":"Melanoma Res"},{"key":"1959_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11060-018-2950-1","volume":"140","author":"EF Garner","year":"2018","unstructured":"Garner EF, Stafman LL, Williams AP, Aye JM, Goolsby C, Atigadda VR, Moore BP, Nan L, Stewart JE, Hjelmeland AB et al (2018) UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts. J Neurooncol 140:209\u2013224. https:\/\/doi.org\/10.1007\/s11060-018-2950-1","journal-title":"J Neurooncol"},{"issue":"1050\u20131062","key":"1959_CR32","doi-asserted-by":"publisher","first-page":"e1014","DOI":"10.1016\/j.cell.2018.01.038","volume":"172","author":"L Garzia","year":"2018","unstructured":"Garzia L, Kijima N, Morrissy AS, De Antonellis P, Guerreiro-Stucklin A, Holgado BL, Wu X, Wang X, Parsons M, Zayne K et al (2018) A hematogenous route for medulloblastoma leptomeningeal metastases. Cell 172(1050\u20131062):e1014. https:\/\/doi.org\/10.1016\/j.cell.2018.01.038","journal-title":"Cell"},{"key":"1959_CR33","doi-asserted-by":"publisher","first-page":"eaaf2968","DOI":"10.1126\/scitranslmed.aaf2968","volume":"9","author":"S Gholamin","year":"2017","unstructured":"Gholamin S, Mitra SS, Feroze AH, Liu J, Kahn SA, Zhang M, Esparza R, Richard C, Ramaswamy V, Remke M et al (2017) Disrupting the CD47-SIRPalpha anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors. Sci Transl Med 9:eaaf2968. https:\/\/doi.org\/10.1126\/scitranslmed.aaf2968","journal-title":"Sci Transl Med"},{"key":"1959_CR34","doi-asserted-by":"publisher","first-page":"995","DOI":"10.3390\/cells12070995","volume":"12","author":"U Gopal","year":"2023","unstructured":"Gopal U, Monroe JD, Marudamuthu AS, Begum S, Walters BJ, Stewart RA, Washington CW, Gibert Y, Zachariah MA (2023) Development of a triple-negative breast cancer leptomeningeal disease model in zebrafish. Cells 12:995. https:\/\/doi.org\/10.3390\/cells12070995","journal-title":"Cells"},{"key":"1959_CR35","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1158\/0008-5472.CAN-16-1836","volume":"77","author":"KB Grausam","year":"2017","unstructured":"Grausam KB, Dooyema SDR, Bihannic L, Premathilake H, Morrissy AS, Forget A, Schaefer AM, Gundelach JH, Macura S, Maher DM et al (2017) ATOH1 promotes leptomeningeal dissemination and metastasis of sonic hedgehog subgroup medulloblastomas. Cancer Res 77:3766\u20133777. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-1836","journal-title":"Cancer Res"},{"key":"1959_CR36","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.canlet.2009.10.020","volume":"291","author":"C Gu","year":"2010","unstructured":"Gu C, Li S, Tokuyama T, Yokota N, Namba H (2010) Therapeutic effect of genetically engineered mesenchymal stem cells in rat experimental leptomeningeal glioma model. Cancer Lett 291:256\u2013262. https:\/\/doi.org\/10.1016\/j.canlet.2009.10.020","journal-title":"Cancer Lett"},{"key":"1959_CR102","doi-asserted-by":"publisher","unstructured":"Hall WA, Myklebust A, Godal A, Nesland JM, Fodstad O (1994) In vivo efficacy of intrathecal transferrin-pseudomonas exotoxin A immunotoxin against LOX melanoma. Neurosurgery 34:649\u2013655; Discussion 655\u2013646. https:\/\/doi.org\/10.1227\/00006123-199404000-00012","DOI":"10.1227\/00006123-199404000-00012"},{"key":"1959_CR37","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1158\/0008-5472.CAN-07-5092","volume":"68","author":"BA Hatton","year":"2008","unstructured":"Hatton BA, Villavicencio EH, Tsuchiya KD, Pritchard JI, Ditzler S, Pullar B, Hansen S, Knoblaugh SE, Lee D, Eberhart CG et al (2008) The Smo\/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread. Cancer Res 68:1768\u20131776. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-5092","journal-title":"Cancer Res"},{"key":"1959_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/BF00165475","volume":"27","author":"U Herrlinger","year":"1996","unstructured":"Herrlinger U, Buchholz R, Jachimczak P, Schabet M (1996) Intrathecal treatment of C6 glioma leptomeningeal metastasis in Wistar rats with interleukin-2. J Neurooncol 27:193\u2013203. https:\/\/doi.org\/10.1007\/BF00165475","journal-title":"J Neurooncol"},{"key":"1959_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/s0165-0270(98)00115-0","volume":"85","author":"KH Janczewski","year":"1998","unstructured":"Janczewski KH, Chalk CL, Pyles RB, Parysek LM, Unger LW, Warnick RE (1998) A simple, reproducible technique for establishing leptomeningeal tumors in nude rats. J Neurosci Methods 85:45\u201349. https:\/\/doi.org\/10.1016\/s0165-0270(98)00115-0","journal-title":"J Neurosci Methods"},{"key":"1959_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40478-014-0085-y","volume":"2","author":"NC Jenkins","year":"2014","unstructured":"Jenkins NC, Kalra RR, Dubuc A, Sivakumar W, Pedone CA, Wu X, Taylor MD, Fults DW (2014) Genetic drivers of metastatic dissemination in sonic hedgehog medulloblastoma. Acta Neuropathol Commun 2:85. https:\/\/doi.org\/10.1186\/s40478-014-0085-y","journal-title":"Acta Neuropathol Commun"},{"key":"1959_CR41","doi-asserted-by":"publisher","first-page":"eade732","DOI":"10.1126\/scitranslmed.ade8732","volume":"15","author":"N Kanaya","year":"2023","unstructured":"Kanaya N, Kitamura Y, Lopez Vazquez M, Franco A, Chen KS, van Schaik TA, Farzani TA, Borges P, Ichinose T, Seddiq W et al (2023) Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas. Sci Transl Med 15:eade732. https:\/\/doi.org\/10.1126\/scitranslmed.ade8732","journal-title":"Sci Transl Med"},{"key":"1959_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02057177","volume":"7","author":"T Kawaguchi","year":"1989","unstructured":"Kawaguchi T, Kawaguchi M, Lembo TM, Nicolson GL (1989) Differential tumor growth of blood-borne B16 melanoma variants in cerebral dura mater is related to tumor-host cell reactions. Clin Exp Metastasis 7:1\u201314. https:\/\/doi.org\/10.1007\/BF02057177","journal-title":"Clin Exp Metastasis"},{"key":"1959_CR43","doi-asserted-by":"publisher","first-page":"abe8671","DOI":"10.1126\/sciadv.abe8671","volume":"7","author":"Y Kitamura","year":"2021","unstructured":"Kitamura Y, Kanaya N, Moleirinho S, Du W, Reinshagen C, Attia N, Bronisz A, Revai Lechtich E, Sasaki H, Mora JL et al (2021) Anti-EGFR VHH-armed death receptor ligand-engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers. Sci Adv 7:abe8671. https:\/\/doi.org\/10.1126\/sciadv.abe8671","journal-title":"Sci Adv"},{"key":"1959_CR44","doi-asserted-by":"publisher","first-page":"1105395","DOI":"10.3389\/fonc.2023.1105395","volume":"13","author":"AJ Knox","year":"2023","unstructured":"Knox AJ, Van Court B, Oweida A, Barsh E, DeSisto J, Flannery P, Lemma R, Chatwin H, Vibhakar R, Dorris K et al (2023) A novel preclinical model of craniospinal irradiation in pediatric diffuse midline glioma demonstrates decreased metastatic disease. Front Oncol 13:1105395. https:\/\/doi.org\/10.3389\/fonc.2023.1105395","journal-title":"Front Oncol"},{"key":"1959_CR45","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/1097-0142(19830101)51:1<154::aid-cncr2820510130>3.0.co;2-k","volume":"51","author":"CP Kokkoris","year":"1983","unstructured":"Kokkoris CP (1983) Leptomeningeal carcinomatosis. How does cancer reach the pia-arachnoid? Cancer 51:154\u2013160. https:\/\/doi.org\/10.1002\/1097-0142(19830101)51:1%3c154::aid-cncr2820510130%3e3.0.co;2-k","journal-title":"Cancer"},{"key":"1959_CR46","first-page":"317","volume":"46","author":"KL Kooistra","year":"1986","unstructured":"Kooistra KL, Rodriguez M, Powis G, Yaksh TL, Harty GJ, Hilton JF, Laws ER Jr (1986) Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat. Cancer Res 46:317\u2013323","journal-title":"Cancer Res"},{"key":"1959_CR47","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1089\/hum.1996.7.3-291","volume":"7","author":"CM Kramm","year":"1996","unstructured":"Kramm CM, Rainov NG, Sena-Esteves M, Chase M, Pechan PA, Chiocca EA, Breakefield XO (1996) Herpes vector-mediated delivery of marker genes to disseminated central nervous system tumors. Hum Gene Ther 7:291\u2013300. https:\/\/doi.org\/10.1089\/hum.1996.7.3-291","journal-title":"Hum Gene Ther"},{"key":"1959_CR48","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/1097-0215(200102)9999:9999<::aid-ijc1173>3.0.co;2-l","volume":"92","author":"B Kusters","year":"2001","unstructured":"Kusters B, Westphal JR, Smits D, Ruiter DJ, Wesseling P, Keilholz U, de Waal RM (2001) The pattern of metastasis of human melanoma to the central nervous system is not influenced by integrin alpha(v)beta(3) expression. Int J Cancer 92:176\u2013180. https:\/\/doi.org\/10.1002\/1097-0215(200102)9999:9999%3c::aid-ijc1173%3e3.0.co;2-l","journal-title":"Int J Cancer"},{"key":"1959_CR49","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s10616-015-9883-8","volume":"68","author":"K Kwist","year":"2016","unstructured":"Kwist K, Bridges WC, Burg KJ (2016) The effect of cell passage number on osteogenic and adipogenic characteristics of D1 cells. Cytotechnology 68:1661\u20131667. https:\/\/doi.org\/10.1007\/s10616-015-9883-8","journal-title":"Cytotechnology"},{"key":"1959_CR50","doi-asserted-by":"publisher","DOI":"10.3791\/62033","author":"V Law","year":"2021","unstructured":"Law V, Baldwin M, Ramamoorthi G, Kodumudi K, Tran N, Smalley I, Duckett D, Kalinski P, Czerniecki B, Smalley KSM et al (2021) A murine ommaya xenograft model to study direct-targeted therapy of leptomeningeal disease. J Vis Exp. https:\/\/doi.org\/10.3791\/62033","journal-title":"J Vis Exp"},{"key":"1959_CR51","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1093\/neuonc\/noac054","volume":"24","author":"V Law","year":"2022","unstructured":"Law V, Chen Z, Vena F, Smalley I, Macaulay R, Evernden BR, Tran N, Pina Y, Puskas J, Caceres G et al (2022) A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma. Neuro Oncol 24:1673\u20131686. https:\/\/doi.org\/10.1093\/neuonc\/noac054","journal-title":"Neuro Oncol"},{"key":"1959_CR53","doi-asserted-by":"publisher","first-page":"e83272","DOI":"10.7554\/eLife.83272","volume":"11","author":"J Li","year":"2022","unstructured":"Li J, Huang D, Lei B, Huang J, Yang L, Nie M, Su S, Zhao Q, Wang Y (2022) VLA-4 suppression by senescence signals regulates meningeal immunity and leptomeningeal metastasis. Elife 11:e83272. https:\/\/doi.org\/10.7554\/eLife.83272","journal-title":"Elife"},{"key":"1959_CR52","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1007\/s12032-010-9580-6","volume":"28","author":"K Li","year":"2011","unstructured":"Li K, Zhang G, Zhao J, Wang X, Li Y, Hu Y (2011) Vascular endothelial growth factor antisense oligonucleotides inhibit leptomeningeal metastasis in vivo. Med Oncol 28:1116\u20131122. https:\/\/doi.org\/10.1007\/s12032-010-9580-6","journal-title":"Med Oncol"},{"key":"1959_CR54","doi-asserted-by":"publisher","first-page":"6007","DOI":"10.2147\/CMAR.S252184","volume":"12","author":"Y Liu","year":"2020","unstructured":"Liu Y, Li Y, Li Z, Li C, He J, Bu H (2020) Knockdown of IKKbeta inhibits tumor development in a leptomeningeal metastasis mouse model and proliferation of lung cancer cells. Cancer Manag Res 12:6007\u20136017. https:\/\/doi.org\/10.2147\/CMAR.S252184","journal-title":"Cancer Manag Res"},{"key":"1959_CR55","first-page":"407","volume":"65","author":"J Miree Jr","year":"1973","unstructured":"Miree J Jr, Gold S (1973) Relationship of survival with number of V-2 carcinoma cells implanted in the subarachnoid space of rabbits. J Natl Med Assoc 65:407\u2013409","journal-title":"J Natl Med Assoc"},{"key":"1959_CR56","first-page":"305","volume":"64","author":"J Miree Jr","year":"1972","unstructured":"Miree J Jr, Harwood TR, Gold S (1972) The implantation of V-2 carcinoma in the subarachnoid space of rabbits. J Natl Med Assoc 64:305\u2013307","journal-title":"J Natl Med Assoc"},{"key":"1959_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41523-023-00550-1","volume":"9","author":"S Morganti","year":"2023","unstructured":"Morganti S, Parsons HA, Lin NU, Grinshpun A (2023) Liquid biopsy for brain metastases and leptomeningeal disease in patients with breast cancer. NPJ Breast Cancer 9:43. https:\/\/doi.org\/10.1038\/s41523-023-00550-1","journal-title":"NPJ Breast Cancer"},{"key":"1959_CR58","first-page":"2146","volume":"54","author":"AT Myklebust","year":"1994","unstructured":"Myklebust AT, Godal A, Fodstad O (1994) Targeted therapy with immunotoxins in a nude rat model for leptomeningeal growth of human small cell lung cancer. Cancer Res 54:2146\u20132150","journal-title":"Cancer Res"},{"key":"1959_CR59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11060-018-2852-2","volume":"139","author":"H Nakagawa","year":"2018","unstructured":"Nakagawa H, Yui Y, Sasagawa S, Itoh K (2018) Evidence for intrathecal sodium butyrate as a novel option for leptomeningeal metastasis. J Neurooncol 139:43\u201350. https:\/\/doi.org\/10.1007\/s11060-018-2852-2","journal-title":"J Neurooncol"},{"key":"1959_CR61","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1158\/1535-7163.MCT-16-0522","volume":"16","author":"S Nanjo","year":"2017","unstructured":"Nanjo S, Arai S, Wang W, Takeuchi S, Yamada T, Hata A, Katakami N, Okada Y, Yano S (2017) MET copy number gain is associated with gefitinib resistance in leptomeningeal carcinomatosis of EGFR-mutant lung cancer. Mol Cancer Ther 16:506\u2013515. https:\/\/doi.org\/10.1158\/1535-7163.MCT-16-0522","journal-title":"Mol Cancer Ther"},{"key":"1959_CR60","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.18632\/oncotarget.6758","volume":"7","author":"S Nanjo","year":"2016","unstructured":"Nanjo S, Ebi H, Arai S, Takeuchi S, Yamada T, Mochizuki S, Okada Y, Nakada M, Murakami T, Yano S (2016) High efficacy of third generation EGFR inhibitor AZD9291 in a leptomeningeal carcinomatosis model with EGFR-mutant lung cancer cells. Oncotarget 7:3847\u20133856. https:\/\/doi.org\/10.18632\/oncotarget.6758","journal-title":"Oncotarget"},{"key":"1959_CR62","doi-asserted-by":"publisher","first-page":"73312","DOI":"10.18632\/oncotarget.20272","volume":"8","author":"G Nayar","year":"2017","unstructured":"Nayar G, Ejikeme T, Chongsathidkiet P, Elsamadicy AA, Blackwell KL, Clarke JM, Lad SP, Fecci PE (2017) Leptomeningeal disease: current diagnostic and therapeutic strategies. Oncotarget 8:73312\u201373328. https:\/\/doi.org\/10.18632\/oncotarget.20272","journal-title":"Oncotarget"},{"key":"1959_CR63","doi-asserted-by":"publisher","first-page":"5906","DOI":"10.3390\/curroncol30060442","volume":"30","author":"A Nguyen","year":"2023","unstructured":"Nguyen A, Nguyen A, Dada OT, Desai PD, Ricci JC, Godbole NB, Pierre K, Lucke-Wold B (2023) Leptomeningeal metastasis: a review of the pathophysiology, diagnostic methodology, and therapeutic landscape. Curr Oncol 30:5906\u20135931. https:\/\/doi.org\/10.3390\/curroncol30060442","journal-title":"Curr Oncol"},{"key":"1959_CR64","doi-asserted-by":"publisher","first-page":"vac059","DOI":"10.1093\/noajnl\/vdac059","volume":"4","author":"S Pan","year":"2022","unstructured":"Pan S, Ye D, Yue Y, Yang L, Pacia CP, DeFreitas D, Esakky P, Dahiya S, Limbrick DD, Rubin JB et al (2022) Leptomeningeal disease and tumor dissemination in a murine diffuse intrinsic pontine glioma model: implications for the study of the tumor-cerebrospinal fluid-ependymal microenvironment. Neurooncol Adv 4:vac059. https:\/\/doi.org\/10.1093\/noajnl\/vdac059","journal-title":"Neurooncol Adv"},{"key":"1959_CR65","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3171\/2022.9.JNS221659","volume":"139","author":"YW Park","year":"2023","unstructured":"Park YW, Han K, Park JE, Ahn SS, Kim EH, Kim J, Kang SG, Chang JH, Kim SH, Lee SK (2023) Leptomeningeal metastases in glioma revisited: incidence and molecular predictors based on postcontrast fluid-attenuated inversion recovery imaging. J Neurosurg 139:38\u201348. https:\/\/doi.org\/10.3171\/2022.9.JNS221659","journal-title":"J Neurosurg"},{"key":"1959_CR66","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1073\/pnas.92.7.2765","volume":"92","author":"IH Pastan","year":"1995","unstructured":"Pastan IH, Archer GE, McLendon RE, Friedman HS, Fuchs HE, Wang QC, Pai LH, Herndon J, Bigner DD (1995) Intrathecal administration of single-chain immunotoxin, LMB-7 [B3(Fv)-PE38], produces cures of carcinomatous meningitis in a rat model. Proc Natl Acad Sci U S A 92:2765\u20132769. https:\/\/doi.org\/10.1073\/pnas.92.7.2765","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1959_CR67","doi-asserted-by":"publisher","first-page":"752","DOI":"10.18632\/oncotarget.336","volume":"2","author":"AS Patel","year":"2011","unstructured":"Patel AS, Allen JE, Dicker DT, Peters KL, Sheehan JM, Glantz MJ, El-Deiry WS (2011) Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases. Oncotarget 2:752\u2013760. https:\/\/doi.org\/10.18632\/oncotarget.336","journal-title":"Oncotarget"},{"key":"1959_CR68","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/1471-2407-13-291","volume":"13","author":"JH Phi","year":"2013","unstructured":"Phi JH, Choi SA, Lim SH, Lee J, Wang KC, Park SH, Kim SK (2013) ID3 contributes to cerebrospinal fluid seeding and poor prognosis in medulloblastoma. BMC Cancer 13:291. https:\/\/doi.org\/10.1186\/1471-2407-13-291","journal-title":"BMC Cancer"},{"key":"1959_CR69","first-page":"6168","volume":"52","author":"PC Phillips","year":"1992","unstructured":"Phillips PC, Than TT, Cork LC, Hilton J, Carson BS, Colvin OM, Grochow LB (1992) Intrathecal 4-hydroperoxycyclophosphamide: neurotoxicity, cerebrospinal fluid pharmacokinetics, and antitumor activity in a rabbit model of VX2 leptomeningeal carcinomatosis. Cancer Res 52:6168\u20136174","journal-title":"Cancer Res"},{"key":"1959_CR70","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1158\/1078-0432.CCR-17-2041","volume":"24","author":"SJ Priceman","year":"2018","unstructured":"Priceman SJ, Tilakawardane D, Jeang B, Aguilar B, Murad JP, Park AK, Chang WC, Ostberg JR, Neman J, Jandial R et al (2018) Regional delivery of chimeric antigen receptor-engineered T cells effectively targets HER2(+) breast cancer metastasis to the brain. Clin Cancer Res 24:95\u2013105. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-2041","journal-title":"Clin Cancer Res"},{"key":"1959_CR72","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1046\/j.1365-2362.2003.01056.x","volume":"33","author":"JC Reijneveld","year":"2003","unstructured":"Reijneveld JC, Taphoorn MJ, Kerckhaert OA, Drixler TA, Boogerd W, Voest EE (2003) Angiostatin prolongs the survival of mice with leptomeningeal metastases. Eur J Clin Invest 33:76\u201381. https:\/\/doi.org\/10.1046\/j.1365-2362.2003.01056.x","journal-title":"Eur J Clin Invest"},{"key":"1959_CR71","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1023\/a:1006237917632","volume":"42","author":"JC Reijneveld","year":"1999","unstructured":"Reijneveld JC, Taphoorn MJ, Voest EE (1999) A simple mouse model for leptomeningeal metastases and repeated intrathecal therapy. J Neurooncol 42:137\u2013142. https:\/\/doi.org\/10.1023\/a:1006237917632","journal-title":"J Neurooncol"},{"key":"1959_CR73","doi-asserted-by":"publisher","first-page":"e1236","DOI":"10.1002\/cnr2.1236","volume":"5","author":"J Remsik","year":"2022","unstructured":"Remsik J, Chi Y, Tong X, Sener U, Derderian C, Park A, Saadeh F, Bale T, Boire A (2022) Leptomeningeal metastatic cells adopt two phenotypic states. Cancer Rep (Hoboken) 5:e1236. https:\/\/doi.org\/10.1002\/cnr2.1236","journal-title":"Cancer Rep (Hoboken)"},{"key":"1959_CR74","doi-asserted-by":"publisher","DOI":"10.1101\/2023.03.17.533041","author":"J Remsik","year":"2023","unstructured":"Remsik J, Tong X, Kunes RZ, Li MJ, Osman A, Chabot K, Sener UT, Wilcox JA, Isakov D, Snyder J et al (2023) Leptomeningeal anti-tumor immunity follows unique signaling principles. BioRxiv. https:\/\/doi.org\/10.1101\/2023.03.17.533041","journal-title":"BioRxiv"},{"key":"1959_CR75","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11060-024-04654-x","volume":"168","author":"AJ Rodrigues","year":"2024","unstructured":"Rodrigues AJ, Chernikova SB, Wang Y, Trinh TTH, Solow-Cordero DE, Alexandrova L, Casey KM, Alli E, Aggarwal A, Quill T et al (2024) Repurposing mebendazole against triple-negative breast cancer CNS metastasis. J Neurooncol 168:125\u2013138. https:\/\/doi.org\/10.1007\/s11060-024-04654-x","journal-title":"J Neurooncol"},{"key":"1959_CR76","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/BF01058455","volume":"23","author":"SM Sagar","year":"1995","unstructured":"Sagar SM, Price KJ (1995) An experimental model of leptomeningeal metastases employing rat mammary carcinoma cells. J Neurooncol 23:15\u201321. https:\/\/doi.org\/10.1007\/BF01058455","journal-title":"J Neurooncol"},{"key":"1959_CR77","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1365-2613.2007.00563.x","volume":"89","author":"N Saito","year":"2008","unstructured":"Saito N, Hatori T, Murata N, Zhang ZA, Nonaka H, Aoki K, Iwabuchi S, Ueda M (2008) Comparison of metastatic brain tumour models using three different methods: the morphological role of the pia mater. Int J Exp Pathol 89:38\u201344. https:\/\/doi.org\/10.1111\/j.1365-2613.2007.00563.x","journal-title":"Int J Exp Pathol"},{"key":"1959_CR79","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/(sici)1096-911x(199708)29:2<92::aid-mpo5>3.0.co;2-m","volume":"29","author":"M Schabet","year":"1997","unstructured":"Schabet M, Martos J, Buchholz R, Pietsch T (1997) Animal model of human medulloblastoma: clinical, magnetic resonance imaging, and histopathological findings after intra-cisternal injection of MHH-MED-1 cells into nude rats. Med Pediatr Oncol 29:92\u201397. https:\/\/doi.org\/10.1002\/(sici)1096-911x(199708)29:2%3c92::aid-mpo5%3e3.0.co;2-m","journal-title":"Med Pediatr Oncol"},{"key":"1959_CR78","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF00177621","volume":"14","author":"M Schabet","year":"1992","unstructured":"Schabet M, Ohneseit P, Buchholz R, Santo-Holtje L, Schmidberger H (1992) Intrathecal ACNU treatment of B16 melanoma leptomeningeal metastasis in a new athymic rat model. J Neurooncol 14:169\u2013175. https:\/\/doi.org\/10.1007\/BF00177621","journal-title":"J Neurooncol"},{"key":"1959_CR80","doi-asserted-by":"publisher","first-page":"e0206394","DOI":"10.1371\/journal.pone.0206394","volume":"14","author":"GM Shackleford","year":"2019","unstructured":"Shackleford GM, Mahdi MY, Moats RA, Hawes D, Tran HC, Finlay JL, Hoang TQ, Meng EF, Erdreich-Epstein A (2019) Continuous and bolus intraventricular topotecan prolong survival in a mouse model of leptomeningeal medulloblastoma. PLoS ONE 14:e0206394. https:\/\/doi.org\/10.1371\/journal.pone.0206394","journal-title":"PLoS ONE"},{"key":"1959_CR81","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s12885-024-12244-3","volume":"24","author":"MX Shi","year":"2024","unstructured":"Shi MX, Ding X, Tang L, Cao WJ, Su B, Zhang J (2024) PROTAC EZH2 degrader-1 overcomes the resistance of podophyllotoxin derivatives in refractory small cell lung cancer with leptomeningeal metastasis. BMC Cancer 24:504. https:\/\/doi.org\/10.1186\/s12885-024-12244-3","journal-title":"BMC Cancer"},{"key":"1959_CR82","first-page":"1341","volume":"40","author":"K Shimizu","year":"1980","unstructured":"Shimizu K, Ushio Y, Hayakawa T, Mogami H (1980) Combination chemotherapy with 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride and bleomycin in meningeal carcinomatosis in rats. Cancer Res 40:1341\u20131343","journal-title":"Cancer Res"},{"key":"1959_CR83","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/BF00150615","volume":"4","author":"T Siegal","year":"1987","unstructured":"Siegal T, Sandbank U, Gabizon A, Siegal T, Mizrachi R, Ben-David E, Catane R (1987) Alteration of blood-brain-CSF barrier in experimental meningeal carcinomatosis. A morphologic and adriamycin-penetration study. J Neurooncol 4:233\u2013242. https:\/\/doi.org\/10.1007\/BF00150615","journal-title":"J Neurooncol"},{"key":"1959_CR84","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"key":"1959_CR86","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1158\/1078-0432.CCR-21-1694","volume":"27","author":"I Smalley","year":"2021","unstructured":"Smalley I, Chen Z, Phadke M, Li J, Yu X, Wyatt C, Evernden B, Messina JL, Sarnaik A, Sondak VK et al (2021) Single-cell characterization of the immune microenvironment of melanoma brain and leptomeningeal metastases. Clin Cancer Res 27:4109\u20134125. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-1694","journal-title":"Clin Cancer Res"},{"key":"1959_CR85","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1158\/1078-0432.CCR-19-2840","volume":"26","author":"I Smalley","year":"2020","unstructured":"Smalley I, Law V, Wyatt C, Evernden B, Fang B, Koomen JM, Welsh EA, Macaulay RJB, Forsyth PA, Smalley KSM (2020) Proteomic analysis of CSF from patients with leptomeningeal melanoma metastases identifies signatures associated with disease progression and therapeutic resistance. Clin Cancer Res 26:2163\u20132175. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2840","journal-title":"Clin Cancer Res"},{"key":"1959_CR87","doi-asserted-by":"publisher","first-page":"1129533","DOI":"10.3389\/fonc.2023.1129533","volume":"13","author":"BJ Soltys","year":"2023","unstructured":"Soltys BJ, Grausam KB, Messerli SM, Hsia CJC, Zhao H (2023) Inhibition of metastatic brain cancer in Sonic Hedgehog medulloblastoma using caged nitric oxide albumin nanoparticles. Front Oncol 13:1129533. https:\/\/doi.org\/10.3389\/fonc.2023.1129533","journal-title":"Front Oncol"},{"key":"1959_CR88","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3171\/JNS\/2008\/108\/2\/0248","volume":"108","author":"D Suki","year":"2008","unstructured":"Suki D, Abouassi H, Patel AJ, Sawaya R, Weinberg JS, Groves MD (2008) Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa. J Neurosurg 108:248\u2013257. https:\/\/doi.org\/10.3171\/JNS\/2008\/108\/2\/0248","journal-title":"J Neurosurg"},{"key":"1959_CR89","doi-asserted-by":"publisher","first-page":"116706","DOI":"10.1016\/j.jns.2020.116706","volume":"411","author":"JP Thakkar","year":"2020","unstructured":"Thakkar JP, Kumthekar P, Dixit KS, Stupp R, Lukas RV (2020) Leptomeningeal metastasis from solid tumors. J Neurol Sci 411:116706. https:\/\/doi.org\/10.1016\/j.jns.2020.116706","journal-title":"J Neurol Sci"},{"key":"1959_CR90","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/00005072-197703000-00003","volume":"36","author":"Y Ushio","year":"1977","unstructured":"Ushio Y, Chernik NL, Posner JB, Shapiro WR (1977) Meningeal carcinomatosis: development of an experimental model. J Neuropathol Exp Neurol 36:228\u2013244. https:\/\/doi.org\/10.1097\/00005072-197703000-00003","journal-title":"J Neuropathol Exp Neurol"},{"key":"1959_CR91","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3171\/jns.1981.55.3.0445","volume":"55","author":"Y Ushio","year":"1981","unstructured":"Ushio Y, Shimizu K, Aragaki Y, Arita N, Hayakawa T, Mogami H (1981) Alteration of blood-CSF barrier by tumor invasion into the meninges. J Neurosurg 55:445\u2013449. https:\/\/doi.org\/10.3171\/jns.1981.55.3.0445","journal-title":"J Neurosurg"},{"key":"1959_CR92","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3171\/jns.1996.85.4.0648","volume":"85","author":"AJ Vincent","year":"1996","unstructured":"Vincent AJ, Esandi MD, van Someren G, Noteboom JL, Avezaat CJ, Vecht C, Smitt PA, van Bekkum DW, Valerio D, Hoogerbrugge PM et al (1996) Treatment of leptomeningeal metastases in a rat model using a recombinant adenovirus containing the HSV-tk gene. J Neurosurg 85:648\u2013654. https:\/\/doi.org\/10.3171\/jns.1996.85.4.0648","journal-title":"J Neurosurg"},{"key":"1959_CR93","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3171\/jns.1996.84.2.0250","volume":"84","author":"FD Vrionis","year":"1996","unstructured":"Vrionis FD, Wu JK, Qi P, Cano WG, Cherington V (1996) Tumor cells expressing the herpes simplex virus-thymidine kinase gene in the treatment of Walker 256 meningeal neoplasia in rats. J Neurosurg 84:250\u2013257. https:\/\/doi.org\/10.3171\/jns.1996.84.2.0250","journal-title":"J Neurosurg"},{"key":"1959_CR94","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1179\/174313209X403904","volume":"31","author":"B Wasita","year":"2009","unstructured":"Wasita B, Kamitani H, Kinoshita Y, Mamun MH, Watanabe T (2009) A rat glioblastoma model with diffuse leptomeningeal gliomatosis induced by intracarotid injection of C6 glioma cells. Neurol Res 31:453\u2013462. https:\/\/doi.org\/10.1179\/174313209X403904","journal-title":"Neurol Res"},{"key":"1959_CR95","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature10825","volume":"482","author":"X Wu","year":"2012","unstructured":"Wu X, Northcott PA, Dubuc A, Dupuy AJ, Shih DJ, Witt H, Croul S, Bouffet E, Fults DW, Eberhart CG et al (2012) Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature 482:529\u2013533. https:\/\/doi.org\/10.1038\/nature10825","journal-title":"Nature"},{"key":"1959_CR96","doi-asserted-by":"publisher","first-page":"763","DOI":"10.2176\/nmc.31.763","volume":"31","author":"M Yamada","year":"1991","unstructured":"Yamada M, Shimizu K, Tamura K, Moriuchi S, Mabuchi E, Park KC, Miyao Y, Hayakawa T (1991) Murine model of leptomeningeal dissemination using human medulloblastoma cells. Neurol Med Chir (Tokyo) 31:763\u2013767. https:\/\/doi.org\/10.2176\/nmc.31.763","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"1959_CR97","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1038\/sj.gt.3302319","volume":"11","author":"WQ Yang","year":"2004","unstructured":"Yang WQ, Senger DL, Lun XQ, Muzik H, Shi ZQ, Dyck RH, Norman K, Brasher PM, Rewcastle NB, George D et al (2004) Reovirus as an experimental therapeutic for brain and leptomeningeal metastases from breast cancer. Gene Ther 11:1579\u20131589. https:\/\/doi.org\/10.1038\/sj.gt.3302319","journal-title":"Gene Ther"},{"key":"1959_CR98","doi-asserted-by":"publisher","first-page":"368ra172","DOI":"10.1126\/scitranslmed.aag0976","volume":"8","author":"Z Yang","year":"2016","unstructured":"Yang Z, Guo Q, Wang Y, Chen K, Zhang L, Cheng Z, Xu Y, Yin X, Bai Y, Rabbie S et al (2016) AZD3759, a BBB-penetrating EGFR inhibitor for the treatment of EGFR mutant NSCLC with CNS metastases. Sci Transl Med 8:368ra172. https:\/\/doi.org\/10.1126\/scitranslmed.aag0976","journal-title":"Sci Transl Med"},{"key":"1959_CR99","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3171\/jns.1986.65.4.0503","volume":"65","author":"T Yoshida","year":"1986","unstructured":"Yoshida T, Shimizu K, Ushio Y, Hayakawa T, Arita N, Mogami H (1986) Development of experimental meningeal gliomatosis models in rats. J Neurosurg 65:503\u2013507. https:\/\/doi.org\/10.3171\/jns.1986.65.4.0503","journal-title":"J Neurosurg"},{"key":"1959_CR100","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s12032-012-0429-z","volume":"30","author":"S Yust-Katz","year":"2013","unstructured":"Yust-Katz S, Mathis S, Groves MD (2013) Leptomeningeal metastases from genitourinary cancer: the University of Texas MD Anderson Cancer Center experience. Med Oncol 30:429. https:\/\/doi.org\/10.1007\/s12032-012-0429-z","journal-title":"Med Oncol"},{"key":"1959_CR101","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1158\/0008-5472.CAN-08-2588","volume":"69","author":"C Zhang","year":"2009","unstructured":"Zhang C, Zhang F, Tsan R, Fidler IJ (2009) Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brain. Cancer Res 69:828\u2013835. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-2588","journal-title":"Cancer Res"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-01959-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-01959-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-01959-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T02:31:43Z","timestamp":1747621903000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-01959-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1959"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-01959-4","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JRT and AUA declare no competing interests.  PK declares:  Consulting Fee (e.g., Advisory Board): Enclear Therapies, Affinia Therapeutics, Biocept, Janssen, Bioclinica, Novocure, Mirati, Servier, Roche, Telix Pharmaceuticals, PlusTherapeutics, Belay Diagnostics, Biodexa  Data Safety Monitoring Community: BPGBio, In8bio Speaker's Bureau: Seagen  Contracted Research: Genentech, Novocure, DNAtrix, Orbus Therapeutics, Servier, Plus Therapeutics   Provisional Patent issued for the treatment of Leptomeningeal Carcinomatosis with ANG1005 Patent Number: WO2016\/205367.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}